Pfizer (PFE) Minority Interest (2009 - 2026)
Pfizer (PFE) posted quarterly Minority Interest of $303.0 million for Q1 2026, up 1.34% year-over-year from $299.0 million in Q1 2025, and up 1.34% quarter-over-quarter from $299.0 million in Q4 2025.
Pfizer (PFE) Minority Interest (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Minority Interest for 18 consecutive years, with $303.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest rose 1.34% year-over-year to $303.0 million; the TTM figure through Mar 2026 stood at $303.0 million (up 1.34% YoY), while the FY2025 annual figure was $299.0 million, up 1.7% from the prior year.
- Minority Interest grew to $303.0 million in Q1 2026 per PFE's latest filing, from $299.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $317.0 million in Q2 2025 and bottomed at $227.0 million in Q3 2022.
- Historically, Minority Interest has averaged $276.4 million across 5 years, with a median of $274.0 million in 2023.
- Annual changes were most pronounced in 2022 — Minority Interest decreased 18.64% — and 2025, when it climbed 15.27%.
- Pfizer's Minority Interest stood at $256.0 million in 2022, then rose by 7.03% to $274.0 million in 2023, then advanced by 7.3% to $294.0 million in 2024, then climbed by 1.7% to $299.0 million in 2025, then gained by 1.34% to $303.0 million in 2026.
- Business Quant data shows PFE's Minority Interest at $303.0 million in Q1 2026, $299.0 million in Q4 2025, and $295.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.23 Bn | 630.47 Bn | 17.26 Bn |
| 2 | AbbVie | 469.32 Bn | 462.76 Bn | 12.70 Bn |
| 3 | Merck | 378.85 Bn | 371.71 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.78 Bn | 295.09 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.59 Bn | 252.69 Bn | 12.86 Bn |
| 6 | Amgen | 236.50 Bn | 222.51 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.49 Bn | 179.31 Bn | 6.22 Bn |
| 8 | Pfizer | 161.62 Bn | 149.92 Bn | 10.94 Bn |
| 9 | Gsk | 105.56 Bn | 101.39 Bn | 8.24 Bn |
| 10 | Sanofi | 55.10 Bn | 47.72 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 302.00 Mn |
| Mar 29, 2026 | 303.00 Mn |
| Dec 31, 2025 | 299.00 Mn |
| Sep 28, 2025 | 295.00 Mn |
| Jun 29, 2025 | 317.00 Mn |
| Mar 30, 2025 | 299.00 Mn |
| Dec 31, 2024 | 294.00 Mn |
| Sep 29, 2024 | 272.00 Mn |
| Jun 30, 2024 | 275.00 Mn |
| Mar 31, 2024 | 276.00 Mn |
| Dec 31, 2023 | 274.00 Mn |
| Sep 30, 2023 | 249.00 Mn |
| Jul 2, 2023 | 274.00 Mn |
| Apr 2, 2023 | 266.00 Mn |
| Dec 31, 2022 | 256.00 Mn |
| Sep 30, 2022 | 227.00 Mn |
| Jul 3, 2022 | 261.00 Mn |
| Apr 3, 2022 | 261.00 Mn |
| Dec 31, 2021 | 262.00 Mn |
| Oct 3, 2021 | 279.00 Mn |